Footnotes Authors Note: Dr Christian Schaaf is now primarily employed at the Institute of Human Genetics at the University Hospital Cologne, Germany
Notably, the effect of tirzepatide as an anti-obesity medication is being investigated in the ongoing SURMOUNT clinical trial programme, in a similar manner to the assessment of semaglutide 2.4 mg for obesity in the Semaglutide Treatment Effect in People with obesity (STEP) programme [27]
Acknowledgments This research was performed using equipment from the Core Centrum Genomic Technologies, Proteomics and Cell Biology in ARRIAM
Store solutions at -20C or -80C
Bydureon BCise and Trulicity come as a liquid in a single-dose injector pen, and each drug is injected once per week
Why GLP-1 Medications Are Gaining Attention Why GLP-1 Medications Are Gaining Attention GLP-1 receptor agonists were first used for type 2 diabetes, but quickly proved to have far broader effects